Qiagen (original) (raw)
Die Qiagen N.V. (eigene Schreibweise: QIAGEN) mit Sitz in Venlo und operativer Zentrale in Hilden bei Düsseldorf ist ein börsennotierter Anbieter von Probenvorbereitungs- und Testtechnologien für die molekulare Diagnostik, akademische Forschung, pharmazeutische Industrie und angewandte Testverfahren mit Standorten in mehr als 25 Ländern.
| Property | Value |
|---|---|
| dbo:abstract | Die Qiagen N.V. (eigene Schreibweise: QIAGEN) mit Sitz in Venlo und operativer Zentrale in Hilden bei Düsseldorf ist ein börsennotierter Anbieter von Probenvorbereitungs- und Testtechnologien für die molekulare Diagnostik, akademische Forschung, pharmazeutische Industrie und angewandte Testverfahren mit Standorten in mehr als 25 Ländern. (de) QIAGEN is a German provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. Consolidated under the Dutch holding QIAGEN N.V., the company operates more than 35 offices in over 25 countries. QIAGEN's shares are listed at the NYSE (using ticker QGEN) and at the Frankfurt Stock Exchange in the Prime Standard (using ticker QIA). Thierry Bernard is the company's Chief Executive Officer. The main operative headquarters are located in Hilden, Germany. (en) QIAGEN (NYSE : QGEN, FWB : QIA) est une société qui vend des kits de biologie moléculaire. Ces produits sont destinés à la préparation d'échantillon en préanalyse et des solutions de . Fondé en 1984, QIAGEN N.V. est maintenant une compagnie de holding néerlandaise avec un centre opérationnel basé à Hilden en Allemagne. Qiagen possède des filiales dans 14 pays et emploie environ 5200 personnes à travers le monde. (fr) La QIAGEN è un produttore di tecnologie per campioni e analisi per la test applicati, per la ricerca accademica e farmaceutica. Consolidata sotto la holding olandese QIAGEN NV, la società gestisce più di 35 uffici in oltre 25 paesi. Le azioni di QIAGEN sono quotate al NYSE (con il ticker QGEN) e alla Borsa di Francoforte nel Prime Standard (con il ticker QIA).La sede operativa principale si trova a Hilden, in Germania; Thierry Bernard è l'amministratore delegato dell'azienda. (it) キアゲン（QIAGEN N.V.）は、DNA、RNAやタンパク質の生体からの抽出・解析などに関連する試薬・体外診断薬および分子診断機器を提供するバイオテクノロジー企業。本社をオランダ・フェンローに、オペレーション本部をドイツ・ノルトライン＝ヴェストファーレン州・Hildenに置き、世界25カ国以上に現地法人を持つ。フランクフルト証券取引所およびニューヨーク証券取引所に上場している（FWB: QIA、NYSE: QGEN）。 (ja) Qiagen (Кайаген, NASDAQ: QGEN, FWB: QIA) — компания, разрабатывающая и производящая оборудование и расходные материалы для молекулярной диагностики, научных и фармацевтических исследований. В голландский холдинг Qiagen N.V. входит более 30 дочерних компаний по всему миру. Акции Qiagen котируются на технологической бирже США Nasdaq (QGEN) и на Франкфуртской фондовой бирже (QIA). Главным исполнительным директором является Peer M. Schatz. Штаб-квартира располагается в Хильдене, Германия, близ Дюссельдорфа. (ru) |
| dbo:assets | 6.146954E9 (dbd:usDollar) |
| dbo:equity | 3.09655E9 (dbd:usDollar) |
| dbo:foundedBy | dbr:Metin_Colpan |
| dbo:foundingDate | 1984-11-29 (xsd:date) |
| dbo:foundingYear | 1984-01-01 (xsd:gYear) |
| dbo:industry | dbr:Biotechnology |
| dbo:location | dbr:United_States dbr:Venlo dbr:Maryland dbr:Germany dbr:Düsseldorf dbr:Hilden dbr:Netherlands |
| dbo:numberOfEmployees | 6000 (xsd:nonNegativeInteger) |
| dbo:operatingIncome | 6.301E8 (dbd:usDollar) |
| dbo:owner | dbr:BlackRock dbr:State_Street_Corp dbr:The_Vanguard_Group,_Inc. dbr:The_Goldman_Sachs_Group,_Inc. dbr:Sun_Life_Financial,_Inc. |
| dbo:owningCompany | dbr:BlackRock dbr:State_Street_Corp dbr:The_Vanguard_Group,_Inc. dbr:The_Goldman_Sachs_Group,_Inc. dbr:Sun_Life_Financial,_Inc. |
| dbo:revenue | 2251.0 (dbd:usDollar) |
| dbo:thumbnail | wiki-commons:Special:FilePath/Qiagen.svg?width=300 |
| dbo:type | dbr:Public |
| dbo:wikiPageID | 3283783 (xsd:integer) |
| dbo:wikiPageLength | 30728 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID | 1105684829 (xsd:integer) |
| dbo:wikiPageWikiLink | dbr:Proteins dbr:Public dbr:MDAX dbr:2009_flu_pandemic dbr:BlackRock dbr:Davidson_Kempner_Capital_Management dbr:DNA dbr:United_States dbr:Venlo dbc:Companies_in_the_TecDAX dbr:Maryland dbr:Frankfurt_Stock_Exchange dbr:Germany dbr:NASDAQ dbr:Thermo_Fisher_Scientific dbc:German_companies_established_in_1984 dbc:Companies_listed_on_the_Frankfurt_Stock_Exchange dbc:Medical_software dbc:Companies_listed_on_the_New_York_Stock_Exchange dbc:German_brands dbr:Düsseldorf dbr:RNA dbr:Hilden dbr:University_of_Düsseldorf dbc:Companies_based_in_North_Rhine-Westphalia dbc:Research_support_companies dbc:Companies_in_the_MDAX dbr:Biotechnology dbc:Biotechnology_companies_established_in_1984 dbr:Taipei dbr:Taiwan dbr:Digene dbc:Biotechnology_companies_of_Germany dbr:CLC_bio dbr:Plasmids dbr:India dbr:Netherlands dbr:New_Delhi dbr:Management_buyout dbr:Plasmid dbr:Russell_1000_Index dbr:NYSE dbr:State_Street_Corp dbr:The_Vanguard_Group,_Inc. dbr:The_Goldman_Sachs_Group,_Inc. dbr:Metin_Colpan dbr:Sun_Life_Financial,_Inc. dbr:File:Qiagen.svg |
| dbp:assets | US $6,146,954,000 (en) |
| dbp:border | 1 (xsd:integer) |
| dbp:equity | US $3,096,550,000 (en) |
| dbp:foundation | 1984-11-29 (xsd:date) |
| dbp:founder | Metin Colpan, Karsten Henco, Jürgen Schumacher (en) |
| dbp:industry | dbr:Biotechnology |
| dbp:keyPeople | Thierry Bernard ( ), Lawrence A. Rosen (en) |
| dbp:location | dbr:United_States dbr:Venlo dbr:Maryland dbr:Germany dbr:Düsseldorf dbr:Hilden dbr:Netherlands |
| dbp:logo | 130 (xsd:integer) |
| dbp:name | QIAGEN N.V. (en) |
| dbp:numEmployees | about 6,000 (en) |
| dbp:operatingIncome | US $630.1 million (en) |
| dbp:owner | dbr:BlackRock dbr:State_Street_Corp dbr:The_Vanguard_Group,_Inc. dbr:The_Goldman_Sachs_Group,_Inc. dbr:Sun_Life_Financial,_Inc. |
| dbp:revenue | US $2,251.7 million (en) |
| dbp:ta | center (en) |
| dbp:title | Qiagen Acquisitions (en) |
| dbp:tradedAs | dbr:MDAX dbr:Russell_1000_Index FWB:QIA (en) NYSE:QGEN (en) |
| dbp:type | dbr:Public |
| dbp:wikiPageUsesTemplate | dbt:Authority_control dbt:Citation_needed dbt:For dbt:Hidden_begin dbt:Hidden_end dbt:Infobox_company dbt:More_citations_needed dbt:Start_date_and_age dbt:TecDAX_companies dbt:Url dbt:Tree_list dbt:Tree_list/end |
| dbp:wordnet_type | http://www.w3.org/2006/03/wn/wn20/instances/synset-company-noun-1 |
| dct:subject | dbc:Companies_in_the_TecDAX dbc:German_companies_established_in_1984 dbc:Companies_listed_on_the_Frankfurt_Stock_Exchange dbc:Medical_software dbc:Companies_listed_on_the_New_York_Stock_Exchange dbc:German_brands dbc:Companies_based_in_North_Rhine-Westphalia dbc:Research_support_companies dbc:Companies_in_the_MDAX dbc:Biotechnology_companies_established_in_1984 dbc:Biotechnology_companies_of_Germany |
| gold:hypernym | dbr:Provider |
| rdf:type | owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 yago:WikicatBiotechnologyCompanies yago:WikicatCompaniesBasedInNorthRhine-Westphalia yago:WikicatCompaniesEstablishedIn1984 yago:WikicatCompaniesInTheNASDAQ-100Index yago:WikicatCompaniesInTheNASDAQBiotechnologyIndex yago:WikicatCompaniesListedOnNASDAQ yago:WikicatCompaniesOfTheNetherlands yago:Abstraction100002137 yago:Company108058098 yago:Group100031264 yago:Institution108053576 yago:Organization108008335 yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity dbo:Organisation yago:SocialGroup107950920 yago:WikicatResearchSupportCompanies |
| rdfs:comment | Die Qiagen N.V. (eigene Schreibweise: QIAGEN) mit Sitz in Venlo und operativer Zentrale in Hilden bei Düsseldorf ist ein börsennotierter Anbieter von Probenvorbereitungs- und Testtechnologien für die molekulare Diagnostik, akademische Forschung, pharmazeutische Industrie und angewandte Testverfahren mit Standorten in mehr als 25 Ländern. (de) QIAGEN is a German provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. Consolidated under the Dutch holding QIAGEN N.V., the company operates more than 35 offices in over 25 countries. QIAGEN's shares are listed at the NYSE (using ticker QGEN) and at the Frankfurt Stock Exchange in the Prime Standard (using ticker QIA). Thierry Bernard is the company's Chief Executive Officer. The main operative headquarters are located in Hilden, Germany. (en) QIAGEN (NYSE : QGEN, FWB : QIA) est une société qui vend des kits de biologie moléculaire. Ces produits sont destinés à la préparation d'échantillon en préanalyse et des solutions de . Fondé en 1984, QIAGEN N.V. est maintenant une compagnie de holding néerlandaise avec un centre opérationnel basé à Hilden en Allemagne. Qiagen possède des filiales dans 14 pays et emploie environ 5200 personnes à travers le monde. (fr) La QIAGEN è un produttore di tecnologie per campioni e analisi per la test applicati, per la ricerca accademica e farmaceutica. Consolidata sotto la holding olandese QIAGEN NV, la società gestisce più di 35 uffici in oltre 25 paesi. Le azioni di QIAGEN sono quotate al NYSE (con il ticker QGEN) e alla Borsa di Francoforte nel Prime Standard (con il ticker QIA).La sede operativa principale si trova a Hilden, in Germania; Thierry Bernard è l'amministratore delegato dell'azienda. (it) キアゲン（QIAGEN N.V.）は、DNA、RNAやタンパク質の生体からの抽出・解析などに関連する試薬・体外診断薬および分子診断機器を提供するバイオテクノロジー企業。本社をオランダ・フェンローに、オペレーション本部をドイツ・ノルトライン＝ヴェストファーレン州・Hildenに置き、世界25カ国以上に現地法人を持つ。フランクフルト証券取引所およびニューヨーク証券取引所に上場している（FWB: QIA、NYSE: QGEN）。 (ja) Qiagen (Кайаген, NASDAQ: QGEN, FWB: QIA) — компания, разрабатывающая и производящая оборудование и расходные материалы для молекулярной диагностики, научных и фармацевтических исследований. В голландский холдинг Qiagen N.V. входит более 30 дочерних компаний по всему миру. Акции Qiagen котируются на технологической бирже США Nasdaq (QGEN) и на Франкфуртской фондовой бирже (QIA). Главным исполнительным директором является Peer M. Schatz. Штаб-квартира располагается в Хильдене, Германия, близ Дюссельдорфа. (ru) |
| rdfs:label | Qiagen (de) Qiagen (it) Qiagen (fr) キアゲン (ja) Qiagen (en) Qiagen (ru) |
| owl:sameAs | freebase:Qiagen yago-res:Qiagen wikidata:Qiagen dbpedia-da:Qiagen dbpedia-de:Qiagen dbpedia-fa:Qiagen dbpedia-fr:Qiagen dbpedia-it:Qiagen dbpedia-ja:Qiagen dbpedia-ru:Qiagen https://global.dbpedia.org/id/2v2t4 |
| skos:closeMatch | http://www.grid.ac/institutes/grid.420167.6 http://www.grid.ac/institutes/grid.421680.9 http://www.grid.ac/institutes/grid.426256.1 http://www.grid.ac/institutes/grid.474454.2 http://www.grid.ac/institutes/grid.481829.e http://www.grid.ac/institutes/grid.482408.2 |
| prov:wasDerivedFrom | wikipedia-en:Qiagen?oldid=1105684829&ns=0 |
| foaf:depiction | wiki-commons:Special:FilePath/Qiagen.svg |
| foaf:isPrimaryTopicOf | wikipedia-en:Qiagen |
| foaf:name | QIAGEN N.V. (en) |
| is dbo:wikiPageDisambiguates of | dbr:QIA |
| is dbo:wikiPageRedirects of | dbr:QGEN_(NASDAQ) dbr:QIAGEN dbr:QIAxpert dbr:QGEN |
| is dbo:wikiPageWikiLink of | dbr:List_of_Turkish_Germans dbr:List_of_University_of_Chicago_Booth_School_of_Business_alumni dbr:List_of_University_of_St._Gallen_people dbr:Bioinformatics_workflow_management_system dbr:Biomatrica dbr:DAX dbr:University_of_St._Gallen dbr:QuantiFERON dbr:QGEN_(NASDAQ) dbr:QIAGEN dbr:QIAxpert dbr:Ruth_March dbr:Peer_M._Schatz dbr:Pyrosequencing dbr:Germantown,_Maryland dbr:Thermo_Fisher_Scientific dbr:LIANTI dbr:Calcium-binding_protein_1 dbr:Stéphane_Bancel dbr:Clinical_metagenomic_sequencing dbr:BLAST_(biotechnology) dbr:Barcelona_Science_Park dbr:Washington_metropolitan_area dbr:Werner_Brandt dbr:Health_Innovation_Manchester dbr:DNA_sequencing dbr:Eric_Xu dbr:PATH_(global_health_organization) dbr:TecDAX dbr:QIA dbr:High-Tech_Gründerfonds dbr:Hilden dbr:Technische_Universität_Darmstadt dbr:DiaSorin dbr:Digene dbr:Borrelia_mayonii dbr:Buffer_P2 dbr:CLC_bio dbr:Nasdaq-100 dbr:Wrocław dbr:Russell_1000_Index dbr:Pacific_Health_Summit dbr:Poly(amidoamine) dbr:Polyhistidine-tag dbr:QGEN |
| is foaf:primaryTopic of | wikipedia-en:Qiagen |
